Our Products

The diverse portfolio of BioARS Therapeutics covers multiple therapeutic areas, including oncology / chemotherapeutics / stem cell transplantation, anti-infectives, and rare diseases (such as Wilson’s disease and Hansen’s disease), effectively addressing the major healthcare challenges presented by these serious conditions.

Hematology / Oncology Cardiology Infections Rare diseases

Hematology / Oncology

ABIRATERONE/STADA

for the treatment of prostate cancer

AXITINIB / STADA

for the treatment of advanced renal cell carcinoma

IMATINIB / KRKA

for the treatment of Ph+ CML and Ph+ ALL

MELPHALAN / TILLOMED

for the treatment of multiple myeloma and advanced ovarian adenocarcinoma

CARMUSTINE / TILLOMED

for the treatment of multiple myeloma, as well as Hodgkin and non-Hodgkin lymphomas.

Cardiology

MIDODRINE / TILLOMED

for the treatment of severe orthostatic hypotension

Infections

EFAVIRENZ / EMTRICITABINE / TENOFOVIR DISOPROXIL KRKA

for the treatment of human immunodeficiency virus-1 infection

EMTRICITABINE / TENOFOVIR DISOPROXIL KRKA

for the treatment of HIV-1 infection / for pre-exposure prophylaxis (PrEP)

Rare diseases

TREPROSTINIL / TILLOMED

for the treatment of idiopathic or heritable pulmonary arterial hypertension

CARGLUMIC ACID / TILLOMED

for the treatment of hyperammonaemia

TRIENTINE / TILLOMED

for the treatment of Wilson’s disease